EP1663221A4 - Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie - Google Patents
Ophthalmische zusammensetzungen zur behandlung der okularen hypertonieInfo
- Publication number
- EP1663221A4 EP1663221A4 EP04782774A EP04782774A EP1663221A4 EP 1663221 A4 EP1663221 A4 EP 1663221A4 EP 04782774 A EP04782774 A EP 04782774A EP 04782774 A EP04782774 A EP 04782774A EP 1663221 A4 EP1663221 A4 EP 1663221A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- ocular hypertension
- ophthalmic compositions
- treating ocular
- treating
- ophthalmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50009003P | 2003-09-04 | 2003-09-04 | |
PCT/US2004/028351 WO2005025568A1 (en) | 2003-09-04 | 2004-08-31 | Ophthalmic compositions for treating ocular hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1663221A1 EP1663221A1 (de) | 2006-06-07 |
EP1663221A4 true EP1663221A4 (de) | 2009-04-22 |
Family
ID=34312180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04782774A Withdrawn EP1663221A4 (de) | 2003-09-04 | 2004-08-31 | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie |
Country Status (7)
Country | Link |
---|---|
US (1) | US7494983B2 (de) |
EP (1) | EP1663221A4 (de) |
JP (1) | JP2007504236A (de) |
CN (1) | CN1842335A (de) |
AU (1) | AU2004271978B2 (de) |
CA (1) | CA2537430A1 (de) |
WO (1) | WO2005025568A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006510742A (ja) | 2002-11-08 | 2006-03-30 | メルク エンド カムパニー インコーポレーテッド | 高眼圧治療用眼科組成物 |
AU2004272546B2 (en) * | 2003-09-04 | 2007-10-18 | Merck Sharp & Dohme Corp. | Ophthalmic compositions for treating ocular hypertension |
US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
US20100298335A1 (en) * | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and Methods for Ameliorating or Reducing Presbyopia |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
US5151444B1 (en) * | 1987-09-18 | 1999-07-06 | R Tech Ueno Ltd | Ocular hypotensive agents |
WO1989010757A1 (en) | 1988-05-10 | 1989-11-16 | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis | New ophthalmic preparation for treating glaucoma |
DE68929435T2 (de) * | 1988-09-06 | 2003-07-17 | Pharmacia Ab | Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5922773A (en) | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
JPH08511024A (ja) | 1993-06-08 | 1996-11-19 | バイディ ファーマシューティカルズ | 眼内圧を低下させる方法および組成物 |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
US5573758A (en) | 1995-04-28 | 1996-11-12 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
US5925342A (en) * | 1996-11-13 | 1999-07-20 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
US6586468B1 (en) | 1998-09-14 | 2003-07-01 | Ono Pharmaceutical Co., Ltd. | ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient |
TWI262914B (en) * | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
PE20010306A1 (es) * | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
CN1413190A (zh) | 1999-12-22 | 2003-04-23 | 辉瑞产品公司 | 治疗骨质疏松的ep4受体选择性激动剂 |
AU2001216072A1 (en) | 2000-03-17 | 2001-10-03 | Alcon, Inc. | 6-hydroxy-indazole derivatives for treating glaucoma |
BR0017163A (pt) * | 2000-03-17 | 2003-01-14 | Alcon Inc | Derivados 5-hidróxi-indazol para tratamento do glaucoma |
EP1186287A1 (de) | 2000-03-31 | 2002-03-13 | Toray Industries, Inc. | Haarwachstums- oder haarbildungsregulatoren |
WO2002024647A1 (fr) | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
IL155368A0 (en) | 2000-11-27 | 2003-11-23 | Pfizer Prod Inc | Ep4 receptor selective agonists in the treatment of osteoporosis |
EP1392292B1 (de) * | 2001-06-01 | 2006-03-01 | Alcon, Inc. | Pyranoindazole und ihre verwendung in der glaukombehandlung |
JP2006510742A (ja) * | 2002-11-08 | 2006-03-30 | メルク エンド カムパニー インコーポレーテッド | 高眼圧治療用眼科組成物 |
US7053085B2 (en) | 2003-03-26 | 2006-05-30 | Merck & Co. Inc. | EP4 receptor agonist, compositions and methods thereof |
EP1479675A1 (de) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Indazolderivate als Faktor Xa-Inhibitoren |
-
2004
- 2004-08-31 US US10/570,231 patent/US7494983B2/en not_active Expired - Fee Related
- 2004-08-31 EP EP04782774A patent/EP1663221A4/de not_active Withdrawn
- 2004-08-31 WO PCT/US2004/028351 patent/WO2005025568A1/en active Application Filing
- 2004-08-31 CA CA002537430A patent/CA2537430A1/en not_active Abandoned
- 2004-08-31 JP JP2006525401A patent/JP2007504236A/ja active Pending
- 2004-08-31 CN CNA2004800243370A patent/CN1842335A/zh active Pending
- 2004-08-31 AU AU2004271978A patent/AU2004271978B2/en not_active Ceased
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
WO2005025568A1 (en) | 2005-03-24 |
CN1842335A (zh) | 2006-10-04 |
CA2537430A1 (en) | 2005-03-24 |
AU2004271978A1 (en) | 2005-03-24 |
AU2004271978B2 (en) | 2009-02-05 |
JP2007504236A (ja) | 2007-03-01 |
EP1663221A1 (de) | 2006-06-07 |
US20070027188A1 (en) | 2007-02-01 |
US7494983B2 (en) | 2009-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1646614A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
EP1732484A4 (de) | Ophthalmisches implantat zur behandlung von glaukom | |
HK1218620A1 (zh) | 眼用組合物和治療眼睛的方法 | |
EP1664011A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
EP1638508A4 (de) | Shunt für die glaukombehandlung | |
EG24420A (en) | Treatment of ophthalmic conditions | |
EP1666027A4 (de) | Ophthalmische zusammensetzung für kontaktlinse | |
PL377172A1 (pl) | Kompozycje do oczu do leczenia nadciśnienia śródgałkowego | |
EP1515722A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
HK1071301A1 (en) | Ophthalmic composition comprising ascomycin | |
EP1581503A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
GB0419174D0 (en) | Compositions and methods for the treatment of glaucoma and ocular hypertension | |
EP1796675A4 (de) | Zusammensetzungen und verfahren zur behandlung von augenerkrankungen | |
EP1771170A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
EP1515721A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
EP2032130A4 (de) | Ophthalmische zusammensetzungen zur behandlung von augenhochdruck | |
EP1802300A4 (de) | Ophthalmische zusammensetzungen zur behandlung von augenhochdruck | |
EP1661573A4 (de) | Ophthalmische zusammensetzung | |
EP1663221A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
EP1647273A4 (de) | Ophthalmische zusammensetzung | |
EP1610776A4 (de) | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie | |
EP1674091A4 (de) | Ophthalmische zusammensetzung zur behandlung von lakrimal-erkrankungen | |
AU2003216547A8 (en) | Compositions and methods for treating glaucoma and ocular hypertension | |
AU2003300471A8 (en) | Methods for treating ocular diseases | |
AU2003215820A8 (en) | Method for treating ocular hypertension and glaucoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060404 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: LT LV |
|
RAX | Requested extension states of the european patent have changed |
Extension state: LV Payment date: 20060404 Extension state: LT Payment date: 20060404 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090324 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20100112 |